Smith wasn't watching the suit.
He was watching the video, and what he was actually tracking was the application set — infiltration at insect scale, surveillance deployment, what the promotional material called "removing obstacles to peace," which was a phrase that meant something specific when you unpacked it. The shrink-to-sub-millimeter capability, applied to a human body with full retained mass and strength. The promotional footage showed it taking down armed helicopters, bypassing physical security by entering through keyholes and cable ducts, accessing hard drives by navigating between the chassis gaps. All of it was real capability, demonstrated on actual systems, not CG.
What he was thinking about was the quantum realm.
In at least one adjacent timeline, a quantum virus had spread from that dimensional layer into the physical universe and consumed every organic system it encountered. No resistance. No ceiling. Immune to enhanced physiology, immune to conventional intervention, immune to everything except solutions that didn't exist until after Earth was already gone. He knew the chain: quantum research, quantum access, quantum contamination. The specific sequence in which that catastrophe had assembled itself.
Pym Particles accessed the quantum realm as a transient phenomenon — the scaling process passed through that layer briefly, creating a window of dimensional contact. Small windows, short duration, apparently harmless. But windows. And windows could be left open too long, or opened too many times, or opened in the wrong configuration.
Bulma had been cautious with Ava Starr's treatment for exactly this reason. The quantum phasing that constituted Ghost's ability was stable-state quantum contact, not transient access, which was a different category of risk — but it was still quantum realm interface, and Smith had told Bulma to keep the research isolated and controlled.
Darren Cross was about to sell this technology to defense procurement agencies, intelligence organizations, and anyone with the order volume to justify his production ramp.
I hope my worries are unfounded, Smith thought, watching Darren walk through the application set. But I need eyes on this.
In the audience, one of the wealthy attendees — a man who had made his money in private security — raised his hand during the Q&A segment and spoke before Darren had fully acknowledged him.
"The ability is impressive," he said. "But what happens when our adversaries have this technology? We've already seen what happens when AI systems get out of hand. What's to prevent the Yellowjacket suit from becoming the next Ultron?"
Darren's smile held. He'd been waiting for this version of the question, because this version was easier than the version about Pym Particle safety.
"There's a reason we don't give up firearms because some people misuse them," he said. "Every tool creates risk. The question is whether the protective applications outweigh the destructive ones. We believe the Yellowjacket suit falls clearly on the protective side."
The man in the audience didn't look convinced. "Zola was a scientist who thought his project was protective."
"Zola was HYDRA," Darren said flatly, and moved to his closing. "That's not a comparable analogy. Thank you all for your attention. I look forward to discussing specific applications with interested parties."
The applause was the kind that means some people are enthusiastic and most people are processing.
Hill was waiting when Darren came off the stage.
She'd positioned herself at the floor-level exit from the main hall — not blocking it, but making herself findable, which was a different and more effective thing. She had a business card already between two fingers.
"Dr. Cross." She extended her hand. "Maria Hill, SWORD. We're interested in what you've built."
Darren shook her hand and took the card before she'd fully extended it. "How interested?"
"Twenty percent above asking price, first production batch. Cash settlement within two weeks of delivery confirmation." She kept her voice even. " The infiltration capability you demonstrated has specific applications we've been building toward. The scale advantage addresses problems that conventional assets don't solve."
Darren looked at the card. SWORD's public profile was thin — Fury was keeping the organization's capabilities quiet while the infrastructure built out — but the organizational credibility was established. "How many units?"
"Enough to discuss somewhere private," Hill said. "Do you have a conference room available?"
Darren looked past her at the cluster of other procurement representatives who had been making their way toward the exit when he came off stage. The room backstage was going to be full in ten minutes. He didn't mind that.
"This way," he said.
Bulma watched him go.
"The Pym Particles are what concerns you," she said to Smith. It wasn't a question — she'd been processing the same thread since the moment the suit appeared on screen.
"The suit is a weapon application. Weapons get proliferated; that's a solvable problem, even if it's not a pleasant one." Smith looked at the empty stage. "The Particles access the quantum realm during the scaling process. Every time someone uses the suit, they're creating a brief interface with that dimensional layer."
"Ghost's phasing is different," Bulma said. "Stable-state contact versus transient access."
"Right. But I still have you running the Ghost research in isolation for a reason."
Bulma looked at her hands. She'd been working through the Ava Starr treatment with the specific caution of someone who knows there's a category of risk they don't have complete data on. "You think the proliferation of the suit creates aggregate exposure?"
"I think enough transient accesses in enough locations, over enough time, with enough variation in the particle formulations as different engineers modify the base design—" he paused. "I don't know. That's the problem. I don't know. But the What If scenario is real in at least one adjacent timeline, and the chain that leads there runs through quantum realm access."
Bulma was quiet for a moment. "So you want surveillance on Darren's research."
"And on wherever the suits end up. Which means I need someone I trust watching Pym Technologies." He looked at her. "Coulson's team."
"They have enhanced members," Bulma agreed. "Donnie, Skye, Mike Peterson on rotation."
"If Darren develops the suit to the point where he's wearing it himself and it goes wrong, Coulson's team can handle it." Smith stood. "I'll make the assignment now. We should go."
He reached the briefing call with Coulson before they'd reached the exhibition hall's exit.
Inside the SHIELD airbus center a few blocks from the Chinese Theatre, Coulson's team had spent the morning watching the expo product reveals on a shared screen and debating the relative merits of each announcement.
Donnie had a strong position on the Baymax v2 combat module, which was that the restraint coding was too conservative and would create liability edge cases. Skye thought the Baymax upgrade path — data migration to a new body — was the most elegant product design decision she'd seen from any company. May watched the spaceship announcement with the focused attention of a pilot who was involuntarily calculating approach vectors to Asgard.
Fitz and Simmons were arguing about the wax bath commercialization timeline and whether the formulation had been peer-reviewed by anyone outside the Fraternity.
Coulson walked in with a tablet and the expression he used when interrupting something the team was enjoying because there was work to do.
"New assignment," he said.
The room turned toward him.
"Darren Cross, CEO of Pym Technologies. The Yellowjacket suit he just presented." Coulson put the assignment brief up on the screen. "The director wants eyes on his research and his distribution channels. Surveillance and assessment — we watch, we document, we report."
Skye scanned the file. "What's the concern?"
"Pym Particle research interfaces with the quantum realm," Coulson said. "That's a dimensional layer with unknown risk profiles. The director wants early warning if the research goes in a direction that creates broader problems."
"And if Darren Cross himself becomes a problem?" May asked.
"We assess. We report. We don't act unilaterally." Coulson looked around the room. "This is observation. Straightforward."
The room accepted this with the easy comfort of people who have been on complicated assignments and know what a simple one looks like by comparison.
Darren Cross returned to the Pym Technologies building the following morning carrying tentative purchase agreements from four organizations, something vindicated in the set of his shoulders.
The agreements were tentative because the deliverable — a working suit that could scale a human subject down and back without lethality — was still a research target rather than an existing product. The Pym Particles could shrink matter. They could not yet maintain the specific atomic configuration of a living nervous system through the scaling process. Darren's research team was close. Weeks away, possibly less.
Which was why Frank's visit to his office was poorly timed.
Frank was a materials researcher, mid-career, solid in his work. He'd written memos about the Yellowjacket suit project six times in the past year and kept showing up. Darren had read three of them. He'd stopped opening them after that.
"The presentation was well received," Darren said, when Frank appeared in his doorway.
"Darren." Frank stepped in and closed the door. "I need you to hear me on this."
"I hear you every time you send me a memo."
"The application set you presented — infiltration, decapitation strikes, industrial sabotage — those aren't defensive applications. You dressed them as defensive applications, but they're not." Frank crossed his arms. "Stark Industries won't sell their armor. Vanko Industries won't sell Dynamo Drones. Capsule Corporation's entire military policy is refusal. There's a reason the major players in this space have drawn that line."
"The major players have their reasons," Darren said. "We have ours."
"Our reason seems to be revenue."
Darren looked at him for a long moment. "Frank. You're a researcher. A good one. Your job is to solve the problems I give you, not to audit my business decisions."
"My job—"
"Is to work for this company or to work somewhere else." Darren's voice was even. "I'll remind you that the current research funding, which supports your entire program, comes from the commercialization roadmap you're asking me to abandon."
Frank held his ground. He'd held his ground on all six memos. "There are ethical boundaries in technology development that exist independently of funding models. You know that. I know you know that."
Darren said nothing for a moment. Then: "Take the afternoon."
Frank looked at him.
"You're clearly stressed. Take the afternoon, come back tomorrow with a clearer head." Darren smiled. "We can revisit this conversation when you've had some rest."
Frank left.
Darren waited until his footsteps had faded down the corridor, then opened his desk drawer and removed the particle gun. The housing was yellow, the emitter compact, the targeting system requiring only a point-and-fire interface. He'd designed the user experience himself. He wanted it simple.
He found Frank in the bathroom.
Frank was washing his hands at the sink, back to the door, and turned at the sound of Darren entering. His expression registered several things in quick sequence — surprise, recognition — and then his gaze dropped to the gun at Darren's side.
Darren had the gun at his side, not raised. He set it on the counter beside the paper towel dispenser, within reach but not pointed.
"You're going to keep filing memos," Darren said.
"Yes," Frank said.
"And at some point you'll go outside the company with it. A journalist. A regulator. A competitor." Darren picked up a paper towel from the dispenser and held it out to Frank, whose hands were still wet.
Frank took the paper towel. He dried his hands. He put the used paper in the bin rather than handing it back, which meant his hands were empty.
"What are you going to do, Darren?" Frank said. His voice was even. "I don't think you've actually thought through what you're going to do."
"I've been thinking about it," Darren said, "for about twenty minutes."
He picked up the gun and fired.
The scaling effect was instantaneous — the particle beam hit Frank at center mass and the compression ran through him at the speed the formulation was designed to produce, which was fast enough that there was no interval in which the result was something other than conclusive. What remained was small enough to be cleaned up with the paper towel Darren was already holding.
He crouched down and wiped the floor carefully.
He folded the paper towel.
He walked to the toilet and dropped it in.
He flushed, and listened to the sound of the water, and straightened his jacket.